Cleared Traditional

K200584 - xPORT 304 (miCOR) System Lens Fragmentation System (FDA 510(k) Clearance)

Jul 2020
Decision
147d
Days
Class 2
Risk

K200584 is an FDA 510(k) clearance for the xPORT 304 (miCOR) System Lens Fragmentation System. This device is classified as a Unit, Phacofragmentation (Class II - Special Controls, product code HQC).

Submitted by Carl Zeiss Meditec Cataract Technology, Inc. (Reno, US). The FDA issued a Cleared decision on July 31, 2020, 147 days after receiving the submission on March 6, 2020.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.4670.

Submission Details

510(k) Number K200584 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2020
Decision Date July 31, 2020
Days to Decision 147 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement

Device Classification

Product Code HQC - Unit, Phacofragmentation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.4670

Similar Devices - HQC Unit, Phacofragmentation

Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E)
K252052 · Bausch and Lomb, Incorporated · Mar 2026
UNITY VCS (8065000296)
K233876 · Alcon Laboratories, Inc. · Jun 2024
Centurion™ Vision System (Active Sentry™) (8065753057)
K233902 · Alcon Laboratories, Inc. · Jan 2024
QUATERA 700
K230858 · Carl Zeiss Meditec, AG · Jul 2023
QUATERA 700
K212241 · Carl Zeiss Meditec, AG · Apr 2022